Vatinid 1 mg tablete
| Name | Vatinid 1 mg tablete |
|---|---|
| Marketing Authorisation Number | HR-H-830238572 |
| Active Substance | repaglinid |
| Composition | svaka tableta sadrži 1 mg repaglinida |
| Pharmaceutical Form | Tableta |
| Packaging [MA Number for Packaging] | 30 tableta u blisteru, u kutiji [HR-H-830238572-01] 90 tableta u blisteru, u kutiji [HR-H-830238572-02] 120 tableta u blisteru, u kutiji [HR-H-830238572-03] 270 tableta u blisteru, u kutiji [HR-H-830238572-04] |
| Manufacturer | Laboratori Fundacio Dau, Barcelona, Španjolska |
| Marketing Authorisation Holder | Novatin Limited, 230, Second Floor, Eucharistic Congress Road, Mosta, Malta |
| Marketing Authorisation Date | 30.09.2022 |
| MA Period of Validity | 30.09.2027 |
| Classification Number | UP/I-530-09/22-01/91 |
| Registration Number | 381-12-01/171-22-06 |
| Prescription | na recept |
| Type of prescription | ponovljivi recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | A10BX02 |
| Medicinal product marketed in the Croatia | Da |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Summary of risk management plan | download |
